Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area
Background: We evaluated the efficacy of the Siemens SARS-CoV-2 Total Antibody assay (CV2T) and IgG assay (CV2G) that can detect antibodies against the receptor binding domain of S antigen in patients with COVID-19 in a Tokyo metropolitan area. Methods: Sensitivity and antibody levels were examined...
Guardado en:
Autores principales: | Gene Igawa, Takamasa Yamamoto, Yuna Baba, Konomi Shinozuka, Maiko Yuri, Mitsuru Wakita, Shigeki Misawa, Takashi Miida, Tomohiko Ai, Yoko Tabe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/764d44d58d874542a60686004259eff7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Performance evaluation of Siemens Atellica enhanced estradiol assay
por: Macias-Muñoz Laura, et al.
Publicado: (2020) -
Diagnosis of Zika Virus Infection by Peptide Array and Enzyme-Linked Immunosorbent Assay
por: Nischay Mishra, et al.
Publicado: (2018) -
Dificultad para el diagnóstico clínico temprano del dengue en un área endémica y su impacto sobre el manejo médico inicial
por: Aralí Martínez-Vega,Ruth, et al.
Publicado: (2006) -
SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Hiroshi Fukuda, et al.
Publicado: (2021) -
Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Hiroshi Fukuda, et al.
Publicado: (2021)